NCT03314857View on ClinicalTrials.gov

China XT: Safety and Effectiveness of Edwards Lifesciences SAPIEN XT THV in the Chinese Population

NACompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

September 18, 2017

Primary Completion Date

July 6, 2018

Study Completion Date

June 15, 2023

Conditions
Aortic StenosisSymptomatic Aortic StenosisAortic Regurgitation
Interventions
DEVICE

SAPIEN XT THV with the NovaFlex+ delivery system

Edwards SAPIEN XT™ Transcatheter Heart Valve along with NovaFlex+ delivery system

Trial Locations (3)

Unknown

WestChina Hospital, Sichuan University, Sichuan

Fuwai Hospital, CAMS&PUMC, Beijing

The Second Affiliated Hospital of Zhejiang University School of, Hangzhou

Sponsors
All Listed Sponsors
lead

Edwards Lifesciences

INDUSTRY